Today marks a pivotal milestone in Alise Pharma's journey. We are thrilled to announce the official opening of our new Innovation Center in Cambridge, Massachusetts — a 42,000-square-foot facility dedicated to pushing the boundaries of supplement science. This center represents our largest single investment in research and development to date, and it signals a bold new chapter in how we develop, test, and bring products to market.

The Cambridge Innovation Center is not simply a bigger lab. It is a purpose-built environment designed to accelerate every stage of the product development pipeline, from early-stage ingredient discovery through formulation, stability testing, and clinical validation. Our goal is to cut the average time from concept to shelf by 40 percent while raising the bar on scientific rigor.

Why Cambridge

Cambridge is home to one of the densest concentrations of biomedical talent in the world. Within a few square miles, you will find Harvard, MIT, the Broad Institute, and dozens of biotech companies working at the frontier of human health. By planting our flag here, we gain direct access to world-class researchers, emerging science, and a vibrant community of innovators who share our mission of improving health outcomes through evidence-based nutrition.

Proximity matters. Many of our upcoming collaborations — including partnerships with academic institutions and clinical research organizations — will be significantly easier to manage with a physical presence in this ecosystem. We have already begun conversations with several research groups whose work in nutrient bioavailability and gut-brain signaling aligns closely with our product roadmap.

Next-Generation Delivery Systems

One of the primary focus areas for the Innovation Center is advanced delivery technology. The supplement industry has long struggled with a fundamental challenge: many of the most promising ingredients are poorly absorbed by the human body. Curcumin, CoQ10, resveratrol, and numerous fat-soluble vitamins all suffer from low bioavailability when delivered in conventional capsule or tablet form.

Our new facility houses a dedicated delivery systems lab equipped with nano-emulsion processing equipment, liposomal encapsulation technology, and advanced coating systems for targeted intestinal release. Early work in this lab has already produced a curcumin formulation that demonstrated 40x improved absorption in preliminary testing. We expect to apply these techniques across our entire product line over the coming years, ensuring that every milligram you take actually reaches the tissues where it is needed.

Personalized Supplement Formulations

The second major initiative at the Cambridge center is personalized nutrition. We believe the future of supplementation is not one-size-fits-all. Differences in genetics, microbiome composition, lifestyle, and health goals mean that two people can respond very differently to the same supplement stack. What works for a 25-year-old endurance athlete is not the same as what works for a 60-year-old managing joint stiffness.

Our personalization team is developing an assessment platform that combines self-reported health data with biomarker analysis to generate individualized supplement recommendations. The Innovation Center includes a dedicated formulation suite where small-batch, personalized blends can be produced with pharmaceutical-grade precision. While this program is still in early development, we anticipate launching a pilot program for select customers in late 2026.

Expanded R&D Capabilities

Beyond delivery systems and personalization, the new facility significantly expands our core R&D capacity. The center includes a full analytical chemistry lab for in-house purity and potency testing, a stability chamber suite for accelerated shelf-life studies, and a sensory evaluation lab for optimizing product taste and texture — a factor that directly impacts consumer compliance.

We are also doubling the size of our research team. Over the next 12 months, we plan to add 35 new positions at the Cambridge center, including analytical chemists, formulation scientists, clinical research coordinators, and data scientists. These hires will support our expanding pipeline of clinical trials and allow us to bring more products through rigorous human studies before launch.

What This Means for Our Customers

For our customers, the Innovation Center translates directly into better products, faster. Our improved delivery technologies will mean higher-potency formulations with fewer capsules per serving. Our personalization research will eventually offer truly tailored supplement regimens. And our expanded testing capabilities will reinforce the transparency and quality assurance that Alise Pharma customers have come to expect.

We founded Alise Pharma on the belief that supplements should be held to the same scientific standards as pharmaceuticals. The Cambridge Innovation Center is the physical embodiment of that belief. We are investing in the infrastructure, talent, and technology needed to deliver on our promise — and we cannot wait to share what comes next.